TaiRxROCO:6580 74 PB Ratio is 3.31 as of Jul. 12, 2026, which is 17% below its 10-year median of 3.97. GuruFocus rates ROCO:6580 with a GF Score™ of 74/100 and a GF Value™ of NT$107.47 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,231 Biotechnology companies, TaiRx ranks worse than 54.59% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), TaiRx's share price is NT$13.05. TaiRx's Book Value per Share for the quarter that ended in Dec. 2025 was NT$3.94. Hence, TaiRx's PB Ratio of today is 3.31.
Good Sign:
TaiRx Inc stock PB Ratio (=3.31) is close to 5-year low of 3.07.
The historical rank and industry rank for TaiRx's PB Ratio or its related term are showing as below:
ROCO:6580'
s PB Ratio Range Over the Past 10 Years
Min: 1.88 Med: 3.97 Max: 10.67
Current: 3.31
During the past 11 years, TaiRx's highest PB Ratio was 10.67. The lowest was 1.88. And the median was 3.97.
ROCO:6580's PB Ratio is ranked worse than 54.59% of 1231
companies
in the Biotechnology industry
Industry Median: 2.93
vs ROCO:6580: 3.31
During the past 12 months, TaiRx's average Book Value Per Share Growth Rate was -32.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -8.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -11.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -10.90% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of TaiRx was -6.90% per year. The lowest was -22.90% per year. And the median was -8.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
TaiRx PB Ratio Related Terms
TaiRx PB Ratio Historical Data
* Premium members only.
The historical data trend for TaiRx's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6580 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, TaiRx's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiRx PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TaiRx's PB Ratio distribution charts can be found below:
* The bar in red indicates where TaiRx's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
TaiRx's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
TaiRx (ROCO:6580) has a PB Ratio of 3.31 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TaiRx and its competitors. This is 17% below median its historical median of 3.97. Over the past decade, TaiRx's PB Ratio has ranged from 1.88 to 10.67. According to the industry distribution chart, TaiRx ranks #672 out of 1231 companies in the Biotechnology industry, placing it in the top 54.6%.
Is TaiRx's PB Ratio too high?
TaiRx's current PB Ratio of 3.31 is 17% below median its 10-year median of 3.97. Over the past 10 years, this metric has ranged from a low of 1.88 to a high of 10.67. The Biotechnology industry median PB Ratio is 2.93. TaiRx's value of 3.31 is 13% above this industry median. Based on the distribution chart, TaiRx ranks #672 out of 1231 companies in the Biotechnology industry, which is below the industry midpoint. Overall, TaiRx has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiRx's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TaiRx ranks #672 out of 1231 companies for PB Ratio. This places TaiRx in the lower half of its industry. The industry median PB Ratio is 2.93. TaiRx's value of 3.31 is 13% above this benchmark. Historically, TaiRx's own PB Ratio has ranged from 1.88 to 10.67 over the past decade. While the company's 10-year median is 3.97 vs. the industry median of 2.93, TaiRx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.93, based on 1,231 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiRx's current PB Ratio of 3.31 is 13% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TaiRx and its competitors. For the Biotechnology industry, the median PB Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiRx's current PB Ratio is 3.31, which is 17% below median its own 10-year median of 3.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiRx stock overvalued right now?
Based on GuruFocus' analysis, TaiRx (ROCO:6580) is currently considered Possible Value Trap. The stock's GF Value™ is NT$107.47, compared to a current price of NT$13.05 — trading 87.9% below its estimated fair value. The current PB Ratio is 3.31, which is 17% below median its 10-year median of 3.97 and 13% above the Biotechnology industry median of 2.93. TaiRx's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For TaiRx (ROCO:6580), the current PB Ratio is 3.31 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiRx (ROCO:6580) Overvalued in 2026?
Based on GuruFocus' analysis, TaiRx stock appears to be undervalued.
The current stock price of NT$13.05 is trading 87.9% below its estimated GF Value™ of NT$107.47.
GuruFocus considers TaiRx to be Possible Value Trap.
Key valuation signals for ROCO:6580:
PB Ratio: 3.31 (17% below median its 10-year median of 3.97)
GF Value™: NT$107.47 vs. price of NT$13.05 (87.9% below fair value)
Industry Position: 13% above the Biotechnology median (#672 of 1231)
No single metric tells the full story. See the ROCO:6580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.
74GF Score
Get the complete analysis for ROCO:6580
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6580 has been successfully added to your 
